Sfoglia per Autore RIMINI, MARGHERITA
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
2019-01-01 Salati, M.; Caputo, F.; Cunningham, D.; Marcheselli, L.; Spallanzani, A.; Rimini, M.; Gelsomino, F.; Reggiani-Bonetti, L.; Andrikou, K.; Rovinelli, F.; Smyth, E.; Baratelli, C.; Kouvelakis, K.; Kalaitzaki, R.; Gillbanks, A.; Michalarea, V.; Cascinu, S.; Braconi, C.
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study
2020-01-01 Rimini, Margherita; Casadei-Gardini, Andrea; Ravaioli, Alessandra; Rovesti, Giulia; Conti, Fabio; Borghi, Alberto; Dall'Aglio, Anna Chiara; Bedogni, Giorgio; Domenicali, Marco; Giacomoni, Pierluigi; Tiribelli, Claudio; Bucchi, Lauro; Falcini, Fabio; Foschi, Francesco Giuseppe; Bagnacavallo Study Group, Null
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)]
2022-01-01 Rimini, M.; Macarulla, T.; Burgio, V.; Lonardi, S.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Nappo, F.; Nichetti, F.; Lai, E.; Valgiusti, M.; Cappetta, A.; Fabregat-Franco, C.; Fassan, M.; De Braud, F.; Puzzoni, M.; Frassineti, G. L.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A.
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study
2022-01-01 CASADEI GARDINI, Andrea; Rimini, Margherita; Kudo, Masatoshi; Shimose, Shigeo; Tada, Toshifumi; Suda, Goki; Ji Goh, Myung; Jefremow, Andre; Scartozzi, Mario; Cabibbo, Giuseppe; Campani, Claudia; Tamburini, Emiliano; Tovoli, Francesco; Ueshima, Kazuomi; Aoki, Tomoko; Iwamoto, Hideki; Torimura, Takuji; Kumada, Takashi; Hiraoka, Atsushi; Atsukawa, Masanori; Itobayashi, Ei; Toyoda, Hidenori; Sakamoto, Naoya; Sho, Takuya; Kang, Wonseok; Siebler, Jürgen; Friedrich Neurath, Markus; Burgio, Valentina; Cascinu, Stefano
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study
2022-01-01 Niger, M; Nichetti, F; Casadei-Gardini, A; Rizzato, Md; Pircher, C; Bini, M; Franza, A; Rimini, M; Burgio, V; Sposetti, C; Fornaro, L; Rapposelli, Ig; de Braud, F
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab
2023-01-01 Rimini, Margherita; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa Ramos, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Stefanini, Bernardo; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Burgio, Valentina; Della Corte, Angelo; Ratti, Francesca; De Cobelli, Francesco; Aldrighetti, Luca; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis
2023-01-01 Ratti, F; Marino, R; Pedica, F; Gardini, Ac; Cipriani, F; Rimini, M; Della Corte, A; Cascinu, S; De Cobelli, F; Colombo, M; Aldrighetti, L
Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index
2023-01-01 Persano, M; Rimini, M; Tada, T; Suda, G; Shimose, S; Kudo, M; Cheon, J; Finkelmeier, F; Lim, Hy; Presa, J; Masi, G; Yoo, C; Lonardi, S; Pressiani, T; Piscaglia, F; HCC COLLABORATIVE, Group
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
2023-01-01 Rimini, M; Persano, M; Tada, T; Suda, G; Shimose, S; Kudo, M; Cheon, J; Finkelmeier, F; Lim, Hy; Presa, J; Masi, G; Yoo, C; Lonardi, S; Piscaglia, F; Kumada, T; Casadei-Gardini, A
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients
2023-01-01 Rimini, M.; Fabregat-Franco, C.; Persano, M.; Burgio, V.; Bergamo, F.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Rizzato, M.; Nichetti, F.; Lai, E.; Cappetta, A.; Macarulla, T.; Fassan, M.; De Braud, F.; Pretta, A.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy | 1-gen-2019 | Salati, M.; Caputo, F.; Cunningham, D.; Marcheselli, L.; Spallanzani, A.; Rimini, M.; Gelsomino, F.; Reggiani-Bonetti, L.; Andrikou, K.; Rovinelli, F.; Smyth, E.; Baratelli, C.; Kouvelakis, K.; Kalaitzaki, R.; Gillbanks, A.; Michalarea, V.; Cascinu, S.; Braconi, C. | |
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study | 1-gen-2020 | Rimini, Margherita; Casadei-Gardini, Andrea; Ravaioli, Alessandra; Rovesti, Giulia; Conti, Fabio; Borghi, Alberto; Dall'Aglio, Anna Chiara; Bedogni, Giorgio; Domenicali, Marco; Giacomoni, Pierluigi; Tiribelli, Claudio; Bucchi, Lauro; Falcini, Fabio; Foschi, Francesco Giuseppe; Bagnacavallo Study Group, Null | |
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] | 1-gen-2022 | Rimini, M.; Macarulla, T.; Burgio, V.; Lonardi, S.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Nappo, F.; Nichetti, F.; Lai, E.; Valgiusti, M.; Cappetta, A.; Fabregat-Franco, C.; Fassan, M.; De Braud, F.; Puzzoni, M.; Frassineti, G. L.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A. | |
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study | 1-gen-2022 | CASADEI GARDINI, Andrea; Rimini, Margherita; Kudo, Masatoshi; Shimose, Shigeo; Tada, Toshifumi; Suda, Goki; Ji Goh, Myung; Jefremow, Andre; Scartozzi, Mario; Cabibbo, Giuseppe; Campani, Claudia; Tamburini, Emiliano; Tovoli, Francesco; Ueshima, Kazuomi; Aoki, Tomoko; Iwamoto, Hideki; Torimura, Takuji; Kumada, Takashi; Hiraoka, Atsushi; Atsukawa, Masanori; Itobayashi, Ei; Toyoda, Hidenori; Sakamoto, Naoya; Sho, Takuya; Kang, Wonseok; Siebler, Jürgen; Friedrich Neurath, Markus; Burgio, Valentina; Cascinu, Stefano | |
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study | 1-gen-2022 | Niger, M; Nichetti, F; Casadei-Gardini, A; Rizzato, Md; Pircher, C; Bini, M; Franza, A; Rimini, M; Burgio, V; Sposetti, C; Fornaro, L; Rapposelli, Ig; de Braud, F | |
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab | 1-gen-2023 | Rimini, Margherita; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa Ramos, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Stefanini, Bernardo; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Burgio, Valentina; Della Corte, Angelo; Ratti, Francesca; De Cobelli, Francesco; Aldrighetti, Luca; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea | |
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis | 1-gen-2023 | Ratti, F; Marino, R; Pedica, F; Gardini, Ac; Cipriani, F; Rimini, M; Della Corte, A; Cascinu, S; De Cobelli, F; Colombo, M; Aldrighetti, L | |
Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index | 1-gen-2023 | Persano, M; Rimini, M; Tada, T; Suda, G; Shimose, S; Kudo, M; Cheon, J; Finkelmeier, F; Lim, Hy; Presa, J; Masi, G; Yoo, C; Lonardi, S; Pressiani, T; Piscaglia, F; HCC COLLABORATIVE, Group | |
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis? | 1-gen-2023 | Rimini, M; Persano, M; Tada, T; Suda, G; Shimose, S; Kudo, M; Cheon, J; Finkelmeier, F; Lim, Hy; Presa, J; Masi, G; Yoo, C; Lonardi, S; Piscaglia, F; Kumada, T; Casadei-Gardini, A | |
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients | 1-gen-2023 | Rimini, M.; Fabregat-Franco, C.; Persano, M.; Burgio, V.; Bergamo, F.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Rizzato, M.; Nichetti, F.; Lai, E.; Cappetta, A.; Macarulla, T.; Fassan, M.; De Braud, F.; Pretta, A.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile